title: Changes in circulating human endothelial progenitor cells after brain injury.
abstract: Endothelial progenitor cells (EPCs) are mobilized from the bone marrow to blood circulation in response to tramatic or inflammatory stimulations. Once released, they actively seek and home to the sites of vascular injury to promote vascular repair. We monitored changes of EPC counts in peripheral blood of 29 patients with traumatic brain injury for up to 21 days. We showed that the levels of circulating EPCs within the first 48 h of injury were lower than control subjects, but increased over time-reaching plateau around 7 days post-injury at a level that was significantly higher than controls. The initial EPC reduction, which was severe in patients with severe injury Glasgow Coma Scale [GCS] < 12), differs from the acute increase in EPC counts found in patients with cardiovascular injury. The subsequent increase in circulating EPCs is primarily through bone marrow mobilization because the cells were stained predominantly for CD133, which labels immature EPCs, but not CD34 (which stains cell of endothelial lineage). The increase appeared earlier in male patients and was greater in those younger than 50 years of age. Changes in circulating EPCs during follow-up periods correlated with platelet, but not leukocyte counts. These results suggest that EPC mobilization following traumatic brain injury may take a different course compared to that associated with body or vascular injuries.
authors.affiliation: Department of Neurosurgery, Tianjin Medical University, Tianjin Neurological Institute, Tianjin, China.
authors.forename: Li
authors.initials: L
authors.lastname: Liu
authors.forename: Hui
authors.initials: H
authors.lastname: Liu
authors.forename: Junfeng
authors.initials: J
authors.lastname: Jiao
authors.forename: Junfeng
authors.initials: J
authors.lastname: Jao
authors.forename: Huiquan
authors.initials: H
authors.lastname: Liu
authors.forename: Angela
authors.initials: A
authors.lastname: Bergeron
authors.forename: Jing-Fei
authors.initials: JF
authors.lastname: Dong
authors.forename: Jianning
authors.initials: J
authors.lastname: Zhang
mesh_terms: D000071916:AC133 Antigen; D000293:Adolescent; D000328:Adult; D000368:Aged; D015703:Antigens, CD / Q000378:metabolism; D015415:Biomarkers / Q000378:metabolism; D001854:Bone Marrow Cells / Q000166:cytology / Q000502:physiology; D001930:Brain Injuries / Q000503:physiopathology*; D019070:Cell Lineage / Q000502:physiology; D049109:Cell Proliferation; D002536:Cerebral Arteries / Q000166:cytology / Q000293:injuries / Q000502:physiology*; D042783:Endothelial Cells / Q000166:cytology / Q000502:physiology*; D005260:Female; D006023:Glycoproteins / Q000378:metabolism; D006412:Hematopoietic Stem Cells / Q000166:cytology / Q000502:physiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D018919:Neovascularization, Physiologic / Q000502:physiology*; D010455:Peptides / Q000378:metabolism; D013234:Stem Cells / Q000502:physiology*; D015854:Up-Regulation / Q000502:physiology
chemical_list: D000071916:AC133 Antigen; D015703:Antigens, CD; D015415:Biomarkers; D006023:Glycoproteins; C000606023:PROM1 protein, human; D010455:Peptides